Global Partnerships HBS is actively expanding reach through international collaborations, evidenced by a 2024 partnership with Skintech Medical Cosmetic Clinic in India and a collaboration with Skintech Green Ltd in Kenya, signaling opportunity to license or distribute collagen wound care products in additional markets.

Product Diversification The company offers a range of collagen-based wound care products (sheets, particles, gels) for human and veterinary use, plus OTC lines and animal-specific channels, presenting cross-selling potential to clinics, hospitals, veterinary practices, and retail outlets.

Regulatory Footprint FDA-compliant and ISO 13485 certified operations with a main facility in Maryland and an Indian factory suggest reliability for customers seeking compliant supply, which can be leveraged to win bids and expand into regulated procurement channels.

Clinical Adoption Products are prescription-based in clinical settings with expanding OTC animal applications, offering upsell opportunities through clinic-based reps, catalogs, and targeted campaigns to physicians, veterinarians, and medical distributors.

Growth Signals Recent leadership changes and notable revenue tier (substantial mid-market scale) imply growth momentum; sales teams can target mid-sized healthcare networks, wound care centers, and regional distributors seeking innovative collagen solutions.